Charles Schwab
GOSS icon

Charles Schwab’s Gossamer Bio GOSS Stock Holding History

Charles Schwab’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Sell
992,527
-517,549
-34% -$144K ﹤0.01% 3386
2026
Q1 		$496K Sell
1,510,076
-175,702
-10% -$276K ﹤0.01% 3106
2025
Q4 		$5.23M Sell
1,685,778
-43,856
-3% -$125K ﹤0.01% 2432
2025
Q3 		$4.55M Buy
1,729,634
+108,215
+7% +$239K ﹤0.01% 2482
2025
Q2 		$1.99M Buy
1,621,419
+482,472
+42% +$526K ﹤0.01% 2671
2025
Q1 		$1.25M Sell
1,138,947
-103,032
-8% -$119K ﹤0.01% 2767
2024
Q4 		$1.12M Buy
1,241,979
+13,902
+1% +$11.9K ﹤0.01% 2877
2024
Q3 		$1.21M Sell
1,228,077
-33,520
-3% -$32.2K ﹤0.01% 2861
2024
Q2 		$1.14M Buy
1,261,597
+8,833
+0.7% +$6.61K ﹤0.01% 2885
2024
Q1 		$1.48M Buy
1,252,764
+32,935
+3% +$36.3K ﹤0.01% 2677
2023
Q4 		$1.11M Buy
1,219,829
+139,187
+13% +$103K ﹤0.01% 2794
2023
Q3 		$900K Buy
1,080,642
+651,837
+152% +$751K ﹤0.01% 2833
2023
Q2 		$515K Sell
428,805
-33,892
-7% -$42.2K ﹤0.01% 3042
2023
Q1 		$583K Sell
462,697
-79,358
-15% -$152K ﹤0.01% 2902
2022
Q4 		$1.18M Buy
542,055
+11,870
+2% +$97.7K ﹤0.01% 2727
2022
Q3 		$6.35M Buy
530,185
+132,756
+33% +$1.65M ﹤0.01% 2096
2022
Q2 		$3.33M Sell
397,429
-10,126
-2% -$78.5K ﹤0.01% 2367
2022
Q1 		$3.54M Buy
407,555
+17,050
+4% +$164K ﹤0.01% 2444
2021
Q4 		$4.42M Buy
390,505
+7,938
+2% +$94.3K ﹤0.01% 2408
2021
Q3 		$4.81M Buy
382,567
+20,237
+6% +$186K ﹤0.01% 2396
2021
Q2 		$2.94M Buy
362,330
+42,330
+13% +$367K ﹤0.01% 2593
2021
Q1 		$2.96M Sell
320,000
-17,215
-5% -$174K ﹤0.01% 2538
2020
Q4 		$3.26M Buy
337,215
+606
+0.2% +$5.97K ﹤0.01% 2429
2020
Q3 		$4.18M Buy
336,609
+10,615
+3% +$141K ﹤0.01% 2161
2020
Q2 		$4.24M Buy
325,994
+78,687
+32% +$990K ﹤0.01% 2101
2020
Q1 		$2.51M Buy
247,307
+4,499
+2% +$58.7K ﹤0.01% 2181
2019
Q4 		$3.8M Buy
242,808
+4,154
+2% +$83.7K ﹤0.01% 2169
2019
Q3 		$4.01M Buy
238,654
+131,013
+122% +$2.61M ﹤0.01% 2091
2019
Q2 		$2.39M Buy
107,641
+22,368
+26% +$428K ﹤0.01% 2312
2019
Q1 		$1.85M Buy
+85,273
New +$1.78M ﹤0.01% 2389

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Charles Schwab's GOSS Position: Q2 2026 in Review

Charles Schwab reduced its Gossamer Bio (GOSS) stake by 34% in Q2 2026, selling an estimated $144K and leaving 992,527 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #3386.

Charles Schwab first reported a position in GOSS in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.35M in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Charles Schwab held 992,527 shares of Gossamer Bio worth $163K as of Q2 2026.
  • Charles Schwab sold 517,549 Gossamer Bio shares in Q2 2026, an estimated $144K.
  • Gossamer Bio made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3386 holding.
  • Charles Schwab first reported a position in Gossamer Bio in Q1 2019 and has held it in 30 quarters since.
  • Charles Schwab's Gossamer Bio position peaked at $6.35M in Q3 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.